Literature DB >> 23790258

Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.

Theodore Karatzas1, Ioannis Vasileiadis, Stylianos Kapetanakis, Efthimios Karakostas, George Chrousos, Gregory Kouraklis.   

Abstract

BACKGROUND: The aggressiveness of papillary thyroid carcinoma (PTC) was evaluated by comparing conventional PTC with papillary thyroid microcarcinoma (PTMC). Risk factors associated with differences in clinical and pathologic features were analyzed to provide appropriate surgical management.
METHODS: A total of 539 patients with papillary carcinoma who underwent total thyroidectomy were retrospectively reviewed. The median follow-up period was 32 months.
RESULTS: Of 539 patients, 311 (57.7%) had PTMC, and 228 (42.3%) had conventional PTC. No differences between patients with PTMC and those with PTC were observed in age, gender, and multifocality. PTMC was associated with less frequent bilaterality (P = .002), lymph node metastasis (P < .001), thyroid capsule invasion (P < .001), and disease recurrence (P < .001), and a higher rate of incidental diagnosis (P = .001). There was no statistically significant difference between the prevalence of lymph node metastasis at diagnosis and disease recurrence rate between nonincidental PTMC and conventional PTC (P > .05).
CONCLUSIONS: Incidental PTMC had significantly fewer aggressive tumor features. Nonincidental PTMC presented with aggressive characteristics similar to those of conventional PTC and should be treated likewise. The authors suggest routine total thyroidectomy followed by an adequate exploration of the central neck compartment as a safe treatment.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Papillary thyroid carcinoma; Papillary thyroid microcarcinoma; Prognosis; Risk factors

Mesh:

Year:  2013        PMID: 23790258     DOI: 10.1016/j.amjsurg.2013.02.008

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  21 in total

1.  Long-term outcomes of observation for clinically negative central compartment lymph nodes in papillary thyroid carcinoma.

Authors:  Jie Liu; Zhengang Xu; Zhengjiang Li; Zongmin Zhang; Pingzhang Tang; Shaoyan Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-24       Impact factor: 2.503

2.  Incidental thyroid carcinomas. A retrospective study.

Authors:  A Maturo; L Tromba; L De Anna; G Carbotta; G Livadoti; C Donello; F Falbo; G Galiffa; Antonella Esposito; A Biancucci; S Carbotta
Journal:  G Chir       Date:  2017 Mar-Apr

Review 3.  Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.

Authors:  Paula Soares; Antónia Afonso Póvoa; Miguel Melo; João Vinagre; Valdemar Máximo; Catarina Eloy; José Manuel Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2021-03-02       Impact factor: 3.943

4.  Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Authors:  Nuray Can; Ebru Tastekin; Filiz Ozyilmaz; Yavuz Atakan Sezer; Sibel Guldiken; Necdet Sut; Nurtac Sarikas; Fulya Oz Puyan; Beril Guler; Semra Ayturk; Mehmet Celik
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

5.  Incidental and non-incidental thyroid microcarcinoma.

Authors:  Krzysztof Kaliszewski; Beata Wojtczak; Marta Strutyńska-Karpińska; Tadeusz Łukieńczuk; Zdzisław Forkasiewicz; Paweł Domosławski
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

6.  Using foci number to predict central lymph node metastases of papillary thyroid microcarcinomas with multifocality.

Authors:  Yawen Guo; Zeming Liu; Pan Yu; Chunping Liu; Jie Ming; Ning Zhang; Maimaiti Yusufu; Chen Chen; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  Exposure to Polybrominated Diphenyl Ethers and a Polybrominated Biphenyl and Risk of Thyroid Cancer in Women: Single and Multi-Pollutant Approaches.

Authors:  Nicole C Deziel; Javier Alfonso-Garrido; Joshua L Warren; Huang Huang; Andreas Sjodin; Yawei Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-06       Impact factor: 4.254

8.  E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma.

Authors:  Masanori Nakamura; Naoyoshi Onoda; Satoru Noda; Shinichiro Kashiwagi; Naoki Aomatsu; Kento Kurata; Hidemi Kawajiri; Tsutomu Takashima; Tetsuro Ishikawa; Kosei Hirakawa
Journal:  Mol Clin Oncol       Date:  2013-12-05

9.  CLINICALLY UNDETECTABLE OCCULT THYROID PAPILLARY CARCINOMA PRESENTING WITH CERVICAL LYMPH NODE METASTASIS.

Authors:  E Tastekin; N Can; S Ayturk; M Celik; F Ustun; S Guldiken; A Sezer; H Celik; M Koten
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jan-Mar       Impact factor: 0.877

10.  Predictive factors of contralateral occult carcinoma in patients with papillary thyroid carcinoma: a retrospective study.

Authors:  Xiaohang Chen; Zhenwei Zhong; Muye Song; Jiru Yuan; Ziyang Huang; Jialin Du; Yongchen Liu; Zeyu Wu
Journal:  Gland Surg       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.